OTCMKTS:IVVI

Ivivi Technologies Stock Forecast, Price & News

$0.0000
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00▼
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00▼
$0.00
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Ivivi Technologies, Inc. engages in the design, development, and commercialize of proprietary electrotherapeutic technologies for the non-invasive treatment of acute and chronic disorders of soft tissue. The company was founded on March 9, 1989 and is headquartered in Northvale, NJ.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IVVI
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.ivivitechnologies.com
Phone(201) 476-9600
EmployeesN/A
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Headlines

No headlines for this company have been tracked by MarketBeat.com

MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Medical Sector

1903rd out of 2,011 stocks

Electromedical Equipment Industry

58th out of 60 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.0000
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IVVI News and Ratings via Email

Sign-up to receive the latest news and ratings for IVVI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Ivivi Technologies (OTCMKTS:IVVI) Frequently Asked Questions

What stocks does MarketBeat like better than Ivivi Technologies?

Wall Street analysts have given Ivivi Technologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Ivivi Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Ivivi Technologies' key competitors?

Some companies that are related to Ivivi Technologies include Aksys (AKSY), Escalon Medical (ESMC), Heart Tronics (HRTT), NewCardio (NWCI), Pace Medical (PMDL), Photoelectron (PECN), Positron (POSC), Trimedyne (TMED) and Xcorporeal (XCRP).
View all of IVVI's competitors.

What is Ivivi Technologies' stock symbol?

Ivivi Technologies trades on the OTCMKTS under the ticker symbol "IVVI."

How do I buy shares of Ivivi Technologies?

Shares of IVVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ivivi Technologies' stock price today?

One share of IVVI stock can currently be purchased for approximately $0.00.

What is Ivivi Technologies' official website?

The official website for Ivivi Technologies is www.ivivitechnologies.com.

Where are Ivivi Technologies' headquarters?

Ivivi Technologies is headquartered at 224 S PEGASUS AVENUE, NORTHVALE NJ, 07647.

How can I contact Ivivi Technologies?

Ivivi Technologies' mailing address is 224 S PEGASUS AVENUE, NORTHVALE NJ, 07647. The company can be reached via phone at (201) 476-9600.


This page was last updated on 4/11/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.